Phase I study of Hepatitus C Virus (HCV) entry inhibitor (ITX5061) in liver transplant recipients with HCV infection

Project Details

Short titlePhase I study of Hepatitus C Virus (HCV) entry inhibitor (ITX5061) in liver transplant recipients with HCV infection
StatusFinished
Effective start/end date1/02/1131/01/14